Suchergebnisse - "Buti, Maria"

PubPharm (47)

1

Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeks

enthalten in: Alimentary pharmacology & therapeutics | 2024

von Fung, S. | Pan, C. | Wong, G. | +17

2

Tenofovir Disoproxil Fumarate Reduces the Severity of COVID-19 in Patients with Chronic Hepatitis B

enthalten in: Digestive diseases and sciences | 2023

von Mateos-Muñoz, B. | Buti, M. | Vázquez, I. | +36

3

Effectiveness of entecavir vs tenofovir disoproxil fumarate for functional cure of chronic hepatitis B in an international cohort

enthalten in: Hepatology international | 2022

von Hsu, Y. | Jun, D. | Peng, C. | +43

4

An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B

enthalten in: Journal of hepatology | 2022

von Kim, H. | Lampertico, P. | Nam, J. | +33

5

Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B

enthalten in: The Journal of infectious diseases | 2021

von Hsu, Y. | Yeh, M. | Wong, G. | +27

6

Nucleos(t)ide analogue therapy : The role of tenofovir alafenamide

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2021

von Buti, M. | Marcos-Fosch, C. | Esteban, R.

7

Similar risk of hepatocellular carcinoma during long-term entecavir or tenofovir therapy in Caucasian patients with chronic hepatitis B

enthalten in: Journal of hepatology | 2020

von Papatheodoridis, G. | Dalekos, G. | Idilman, R. | +21

CommentIn: J Hepatol. 2021 Jan;74(1):246-247. - PMID 32988659

8

Application of EASL 2017 criteria for switching hepatitis B patients from tenofovir disoproxil to entecavir or tenofovir alafenamide

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2020

von Roade, L. | Loglio, A. | Borghi, M. | +9

9

Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus-infected patients with renal impairment : results from a 7-year, multicentre retrospective cohort study

enthalten in: Alimentary pharmacology & therapeutics | 2020

von Lampertico, P. | Berg, T. | Buti, M. | +66

CommentIn: Aliment Pharmacol Ther. 2020 Sep;52(5):889-890. - PMID 32852818

10

Hepatocellular carcinoma prediction beyond year 5 of oral therapy in a large cohort of Caucasian patients with chronic hepatitis B

enthalten in: Journal of hepatology | 2020

von Papatheodoridis, G. | Sypsa, V. | Dalekos, G. | +23

CommentIn: J Hepatol. 2020 Jul;73(1):223-224. - PMID 32229038

1
2
3
4
5
Nächster »
[5]